• Topics

  • Formats

Organiser: The MSL

Author(s):  and 

The power of AI as a gamechanger for omnichannel promotional content is becoming well known, especially as large language models (LLMs) evolve in sophistication. Advances in model architecture, improved training techniques, and better handling of nuance, ambiguity, bias, and context make AI increasingly suitable for a range of biopharma functions, including medical affairs. These developments are enabling more efficient, personalized, and consistent delivery of scientific information to healthcare professionals (HCPs) across various channels.

LLMs are transforming how medical affairs teams communicate scientific and medical information, both online and offline. Because HCPs have unique educational backgrounds, therapeutic expertise, and preferences for communication formats, delivering the right information through the right channel at the right time is critical. AI-powered omnichannel engagement allows medical affairs teams to tailor content based on an HCP’s needs, whether it’s detailed clinical data for a specialist or high-level updates for a general practitioner.

However, simply segmenting audiences and creating modular content, as has been done traditionally, no longer guarantees optimal engagement. Today’s medical landscape demands more. LLMs offer the ability to deliver consistent, timely, and evidence-based communications while adapting to HCPs’ evolving preferences. This level of personalization and efficiency is crucial, especially when dealing with multiple content formats such as peer-reviewed articles, online videos, and symposia presentations. While MSLs and CRM tools continue to play a key role, LLMs enable a level of scale and precision previously unattainable. But is it perfect? Not quite.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?